Mizuho Securities analyst Irina Koffler reiterated a Buy rating and $35 price target on Bausch Health Companies (NYSE: BHC) after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE